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Glutamate(Glu)-mediated excitotoxicity plays a major role in the degeneration of motor 
neurons (MNs) in amyotrophic lateral sclerosis (ALS) and reduced astrocytic uptake was 
suggested as a cause for the increased synaptic availability of Glu (Rothstein et al., 
1995). On the basis of our studies, we have proposed that abnormal release may 
represent another source for excessive extracellular Glu levels (Milanese et al., 2011; 
Giribaldi et al., 2013). Thus, targeting Glu release mechanisms that are altered in ALS 
may represent a possible strategy for new therapeutic approaches (Uccelli et al., 2012; 
Milanese et al., 2014). The main goal of this research was to investigate at the synaptic 
level which mechanisms support the excessive Glu exocytosis.  
Synaptic nerve terminals (synaptosomes) were purified from the spinal cord of mice 
expressing high copy number of human SOD1 carrying the G93A point mutation 
(SOD1G93A), the most studied experimental model for human ALS (Gurney et al., 1994), 
and of human WT SOD1-expressing control mice (SOD1). Studies were performed at two 
different stage of the disease, corresponding to the early and the late phase of pathology 
(4 and 17 weeks of life, respectively). As functional readouts we measured the release of 
Glu from superfused synaptosomes and the concentration of Ca2+ by fluorometric analysis 
at the pre-synaptic level. We also measured the expression/activation state of a number 
of pre-synaptic proteins involved in neurotransmitter release by confocal microscopy and 
western blot experiments. 
The results showed that both the spontaneous and the stimulus-evoked exocytotic Glu 
release are increased in SOD1G93A mice at 4 and 17 weeks of life. The expression of a 
number of pre-synaptic proteins (SNAP-25, stx-1A, VAMP-2, synaptophysin, munch-18, 
munch-13, rab2A, synaptotagmin, complexin 1/2, NSF, α/β snap, dynamin, actin and 
myosin) was analyzed. Few of them were found modified and only synaptotagmin 
resulted over-expressed in both 4 and 17 week old SOD1G93A mice. Alteration of the 
cytoskeletal proteins, myosin and actin, was also observed. Increased pre-synaptic Ca2+ 
levels, over-activation of calcium/calmodulin-dependent kinase-II and ERK/MAP kinases 
correlates with hyper-phosphorylation of synapsin-I at both early and late stages of 
disease. In line with these findings, release experiments showed that the excessive Glu 
exocytosis was accompanied by the increase of the readily releasable pool of vesicles. 
Supporting the role of the above protein phosphorylation cascade, the excessive 
glutamate release was prevented by the selective block of synapsin-I phosphorylation, 
using specific antibodies. 
Our results highlight that aberrant glutamate exocytosis is present in the spinal cord of 
late stage SOD1G93A mice, an event accompanied by marked changes of specific pre-
synaptic molecular mechanisms. The same synaptic alterations are also present in 4 
weeks old SOD1G93A mice and could represent a key feature in the early phase of 
experimental ALS, thus playing a pivotal role in the development of the disease. 
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